Clinical Trials Logo

Clinical Trial Summary

The purpose is to investigate whether polyps that look different at endoscopy, have formed via different mutations and have different risks of turning into cancer.


Clinical Trial Description

Laterally spreading tumours (LSTs), are polyps that have a lateral extension along the duodenal wall with minimal vertical growth. It has become evident over the last few years that rather than being a single entity requiring an accumulation of mutations, Duodenal and ampullary cancer is in fact a heterogenous disease forming via multiple distinct genetic pathways. It is therefore hypothesised that different polyp types have different genetic abnormalities, and potentially form via distinct genetic pathways, although this theory has not been widely examined. This knowledge would be important in furthering our understanding of the development of cancer. There is accumulating evidence that genetic abnormalities may be a better predictor of cancer behaviour than histological grade. Additionally, guidelines for endoscopy surveillance are currently a one size fits all approach that do not reflect the genetic heterogeneity of the disease and the knowledge that only 5% of polyps progress to cancer. Genetic studies may assess future cancer risk to a person in polyps once removed and plan surveillance endoscopy frequency. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01556399
Study type Observational
Source Western Sydney Local Health District
Contact
Status Completed
Phase
Start date November 2011
Completion date November 2018

See also
  Status Clinical Trial Phase
Completed NCT06200129 - İmportance of Scattered White Spots Detected in the Duodenum and Their Relationship wıth Zonulin N/A
Completed NCT03288831 - Changes in Intestinal Permeability 4 Hours After Gluten Challenge N/A